These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21474833)

  • 1. Radiologists urge FDA to accept PET-based tumor response criteria in clinical trials.
    Brower V
    J Natl Cancer Inst; 2011 Apr; 103(8):622-4. PubMed ID: 21474833
    [No Abstract]   [Full Text] [Related]  

  • 2. Measuring response with FDG-PET: methodological aspects.
    Allen-Auerbach M; Weber WA
    Oncologist; 2009 Apr; 14(4):369-77. PubMed ID: 19357228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond FDG: Many Molecular Imaging Agents Are in Development.
    Brower V
    J Natl Cancer Inst; 2011 Jan; 103(1):13-5. PubMed ID: 21169540
    [No Abstract]   [Full Text] [Related]  

  • 4. 2014 Cassen Lecture: What have we learned from the National Oncologic PET Registry?
    Siegel BA
    J Nucl Med; 2014 Dec; 55(12):9N-15N. PubMed ID: 25453061
    [No Abstract]   [Full Text] [Related]  

  • 5. 18F-FDG PET as a candidate for "qualified biomarker": functional assessment of treatment response in oncology.
    Larson SM; Schwartz LH
    J Nucl Med; 2006 Jun; 47(6):901-3. PubMed ID: 16741296
    [No Abstract]   [Full Text] [Related]  

  • 6. Q&A: perspective on pediatric nuclear medicine: an interview with Michael J. Gelfand.
    Gelfand MJ
    J Nucl Med; 2006 Apr; 47(4):22N-23N. PubMed ID: 16673553
    [No Abstract]   [Full Text] [Related]  

  • 7. Imaging surrogates of tumor response to therapy: anatomic and functional biomarkers.
    Zhao B; Schwartz LH; Larson SM
    J Nucl Med; 2009 Feb; 50(2):239-49. PubMed ID: 19164218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Imaging in oncology and international rules for evaluation: the nuclear medicine].
    Bourre JC; Vuillez JP
    Bull Cancer; 2009 Nov; 96(11):1127-37. PubMed ID: 19854694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography and neoadjuvant therapy of breast cancer.
    Cochet A; Generali D; Fox SB; Ferrozzi F; Hicks RJ
    J Natl Cancer Inst Monogr; 2011; 2011(43):111-5. PubMed ID: 22043055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDG PET/CT for assessing therapy response in primary thyroid lymphoma.
    Lin EC
    Clin Nucl Med; 2007 Feb; 32(2):152-3. PubMed ID: 17242576
    [No Abstract]   [Full Text] [Related]  

  • 11. Advancing Precision Nuclear Medicine and Molecular Imaging for Lymphoma.
    Wright CL; Maly JJ; Zhang J; Knopp MV
    PET Clin; 2017 Jan; 12(1):63-82. PubMed ID: 27863567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the future of nuclear medicine written in the genes?
    Bengel FM
    Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):309-11. PubMed ID: 14722684
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiagency effort to focus on PET as biomarker.
    J Nucl Med; 2006 Apr; 47(4):11N. PubMed ID: 16673551
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic impact of 18F-FDG uptake on PET in non-small cell lung cancer patients with postoperative recurrence following platinum-based chemotherapy.
    Kaira K; Yamamoto N; Kenmotsu H; Murakami H; Ono A; Naito T; Endo M; Takahashi T
    Respir Investig; 2014 Mar; 52(2):121-8. PubMed ID: 24636268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of PET for evaluation of treatment response in oncology].
    Bourguet P
    Cancer Radiother; 2006 Nov; 10(6-7):334-7. PubMed ID: 16950641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VI. FDG-PET as a biomarker in lymphoma: from qualitative to quantitative analysis.
    Meignan M
    Hematol Oncol; 2015 Jun; 33 Suppl 1():38-41. PubMed ID: 26062052
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnostic value of positron emission tomography (PET) in clinical oncology].
    Czech N; Brenner W; Kampen WU; Henze E
    Dtsch Med Wochenschr; 2000 May; 125(18):565-7. PubMed ID: 10835983
    [No Abstract]   [Full Text] [Related]  

  • 18. [PET-CT scan in Oncology: an extraordinary health care, teaching and investigator opportunity].
    Calvo FA
    Rev Esp Med Nucl; 2007; 26(2):67-8. PubMed ID: 17386232
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Fischman and Thrall editorial, "Who Should Read ... PET Studies".
    Yaeger T
    J Nucl Med; 2004 Nov; 45(11):1975. PubMed ID: 15534071
    [No Abstract]   [Full Text] [Related]  

  • 20. Unparalleled contribution of 18F-FDG PET to medicine over 3 decades.
    Basu S; Alavi A
    J Nucl Med; 2008 Oct; 49(10):17N-21N, 37N. PubMed ID: 18832112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.